investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
Mechanisms of Immune-mediated Tumor Cell Destruction
Thomas Sayers
2 Collaborator(s)
Funding source
National Cancer Institute (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
Neil Cross
Sheffield Hallam University
Sheffield, United Kingdom
Hideo Yagita
Juntendo University
Tokyo, Japan
Thomas Sayers
National Cancer Institute (NIH)
Rockville, United States
Related projects
Khandan Keyomarsi
Targeting the cell cycle in triple negative breast cancer
Breast
Ming Tan
Glucose Metabolism and ErbB2-Mediated Cancer Progression
Breast
Robert A Gatenby
Application of Evolutionary Principles to Maintain Cancer Control (PQ21)
Breast
Agata Smogorzewska
The role of nucleases in interstrand crosslink repair
Breast
Philip Tofilon
Radiation-induced translational control of gene expression
Breast
Radiation Oncology
Gordon Hager
In vivo Imaging Analysis of Steroid/Nuclear Receptor Function
Breast
Mala Pande
Susceptibility Markers for a Breast-Colon Cancer Phenotype
Breast
Theresa A Guise
Differential TGF-Beta Signaling in Bone Microenviroment: Impact on Tumor Growth
Breast
Powel Brown
VADIS TRIAL: PHASE II TRIAL OF E75 PEPTIDE VACCINE IN WOMEN WITH DCIS OF THE BREAST
Breast